Table 1.
Clinical and management features of the 7 recurrent ABC patients.
| Location | Age (years) | Sex | Adjuvant | Bone graft | Time to first recurrence (months) |
|---|---|---|---|---|---|
| Distal HumerusS | 8 | F | NO | Chips, Vitoss | 48 |
| Proximal Humerus | 4 | M | H2O2 | Chips | 24 |
| Distal TibiaS | 8 | M | LN | Chips | 6 |
| Proximal FemurP | 13 | M | Cement | BC | 55 |
| Proximal FemurP | 3 | M | No | DBM | 24 |
| Proximal Femur | 5 | M | LN | DBM, chips | 12 |
| Proximal HumerusP | 8 | M | No | DBM | 37 |
M: male; F: female; H2O2: hydrogen peroxide; LN: liquid nitrogen; BC: bone cement; DBM: demineralized bone matrix; chips: allograft chips; Vitoss: calcium triphosphate bone graft substitute. SSolid ABC variant. PPathological fracture.